Yet how will our system contemplate funding high-cost therapies that deliver potentially curative benefits over such a wide range of years - from 5 to 75 years. …
New CAR-T data once again highlights the evaluation challenge
June 5, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
The COVID-19 vaccine manufacturing and supply deals
September 21, 2020 - - Latest News -
MA: Less access for Australians the 'only likely outcome' of US proposal
September 21, 2020 - - Latest News -
Government pushing options to secure its own 'certainty'
September 21, 2020 - - Latest News -
Emerging Cerecin looking to build its Australian presence
September 21, 2020 - - Latest News -
Greg Hunt announces MRFF funding for more COVID-19 vaccines
September 21, 2020 - - Latest News -
NPS MedicineWise sold access to GP data through its commercial arm
September 18, 2020 - - Latest News -
New report highlights the deadly impact of non-melanoma skin cancer
September 18, 2020 - - Latest News